Delivery Order HHSF223201610028I-75F40120F19008
- The Food and Drug Administration (FDA) awarded a delivery order valued at $816,801.67 to Denver Health and Hospital Authority (doing business as Denver Health) on September 20, 2019, for work related to improving the quality and representativeness of Treatment Center Program data used in post-marketing surveillance of prescription and over-the-counter drug abuse. The contract, which operates under firm fixed-price terms with an ultimate completion date of March 5, 2026, represents work to be...
- This is a $38,403.00 Firm Fixed Price Delivery Order awarded by the Food and Drug Administration (FDA) to Denver Health and Hospital Authority, doing business as Denver Health, a comprehensive healthcare system in Denver, Colorado. The order is for a task titled "Drug Specific Report- Route of Abuse Patterns for Opana ER and Selected Comparator Opioids among Individuals Entering Treatment for Opioid Addictions." This order is placed under the FDA's Prescription Drug Abuse Summary...
- The Food and Drug Administration (FDA) awarded Denver Health and Hospital Authority a $630,211 delivery order on August 31, 2022, to conduct survey research on the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among a general population recruited through an online panel survey. This delivery order operates under the FDA's $10 million multiple-award Indefinite Delivery Contract (IDC) for data resources supporting post-marketing surveillance of...
- This is a $1,353,024.00 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Denver Health and Hospital Authority, doing business as Denver Health, to harness diverse data through information sciences to improve health outcomes, evaluate bias, recruitment, and retention in an online setting, conduct a recruitment and retention optimization study, and perform content validation of questionnaire modules. The contract supports a pilot study for these...
- The U.S. Food and Drug Administration (FDA) awarded a Firm Fixed Price definitive contract valued at $307,622.10 to the Denver Health and Hospital Authority, doing business as Denver Health, to evaluate the impact of flow restrictors on pediatric exposures to liquid single-ingredient acetaminophen. This contract was awarded under a Broad Agency Announcement (BAA) solicitation and does not have a set-aside designation. Denver Health is a large healthcare provider and academic medical center...
- The U.S. Department of Health and Human Services (HHS) awarded a $5,099,064.36 delivery order contract to Denver Health and Hospital Authority (Denver Health) to conduct a study comparing tuberculosis skin tests (TST) and interferon-gamma release assays (IGRAs) in latent tuberculosis infection (LTBI) patients. The contract was issued under the Tuberculosis Epidemiology Studies Consortium, a larger indefinite delivery vehicle held by HHS. The award did not utilize any set-aside designations....
- This firm-fixed-price contract was awarded by the Food and Drug Administration (FDA) to the Colorado Department of Public Health & Environment (CDPHE), a state government entity, to provide Mammography Quality Standards Act (MQSA) inspections. The contract has a ceiling value of $453,010.00 and a period of performance from March 1, 2003, to February 28, 2006. CDPHE, a subsidiary of the City of Lakewood, has a long history of executing federal contracts and grants across various public health...
- Denver Solutions, LLC, an FDA-registered 503B outsourcing facility specializing in compounded sterile pharmaceuticals, was awarded a delivery order valued at $53,375 by Veterans Integrated Service Network 23 (VISN 23) on October 1, 2025, with an ultimate completion date of March 31, 2026. This firm fixed-price contract, which carries no set-aside designation, will be performed in Greenwood Village, Colorado, and involves the provision of 503B compounded pharmaceutical products to support VA...
- This is a $158,450.08 firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Aleut Facilities Support Services, LLC, an Alaskan Native Corporation-owned and small disadvantaged business. The contract is for basic and preventive maintenance services at FDA Building 20 in the Denver Federal Center in Lakewood, Colorado. The contract has a period of performance ending on July 31, 2016. As a competitive 8(a) set-aside contract, it was awarded to Aleut...
- The Department of Health and Human Services Food and Drug Administration awarded a $857,109 firm fixed price delivery order to DRT Strategies, Inc. for data standards program, process and coordination support. The one-year contract, with a period of performance from June 2020 through September 2021, will see DRT Strategies provide services in Arlington, Virginia to assist the FDA in managing its data standardization efforts. No major subcontractors or set aside designations were identified. This...
- FDA Prescription Drug Abuse Summary ReportsMaster IDIQ
- HHSF223201610028IIndefinite Delivery Contract
- HHSF223201610028I-75F40120F19008Delivery Order
This firm fixed-price delivery order was awarded to Denver Health and Hospital Authority, doing business as Denver Health, by the Food and Drug Administration (FDA). The $87,552.08 contract is for Denver Health to provide the RADARS StreetRx dataset and RADARS drug diversion services to support the FDA's post-marketing prescription and over-the-counter drug abuse surveillance efforts. This work is being performed under the FDA Prescription Drug Abuse Summary Reports indefinite delivery/indefinite quantity (IDIQ) contract vehicle. No set-aside designation was used for this award. Denver Health is a 555-bed academic health system and Level I trauma center that frequently partners with federal agencies on data collection, analytics, and public health initiatives through contracts and grants.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
DATA RESOURCE FOR POST-MARKETING PRESCRIPTION DRUG ABUSE SURVEILLANCE DATA FROM INDIVIDUALS ENTERING OR BEING ASSESSED FOR SUBSTANCE ABUSE | FDA-RFP-1168334 | Department of Health and Human Services Food and Drug Administration | Award Notice 1/1 | 6/9/16, 3:06 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Close Out | ($4k) | 11/21/22 | |
| P00001 | Supplemental Agreement for work within scope | $4.0k | 6/21/21 | |
| Not listed | Not listed | $87.6k | 9/9/20 |